首页> 外文期刊>東京慈惠会医科大学雑誌 >The Efficacy of Combination Chemotherapy With Mitoxantrone And High-Dose Cytosine Arabinoside As A Salvage Therapy For Patients With Relapsed Of Refractory Adult Acute Leukemias
【24h】

The Efficacy of Combination Chemotherapy With Mitoxantrone And High-Dose Cytosine Arabinoside As A Salvage Therapy For Patients With Relapsed Of Refractory Adult Acute Leukemias

机译:米托蒽醌与大剂量胞嘧啶阿拉伯糖苷联合化学疗法作为治疗难治性成人急性白血病的有效方法

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated the efficacy of combination chemotherapy with mitoxantrone and high- dose cytosine arabinoside as a salvage therapy in 40 adults with acute leukemia. From May 1987 through October 1997, 17 patients with acute myeloid leukemia and 23 patients with acute lymphoblastic leukemia, whom disease had relapsed or been refractory to previous treatment, received mitoxantrone, 5 mg/m~2/day, on days 1 to 5 and cytosine arabinoside, 2 g/m~2, every 12 hours on days 1 to 3.
机译:我们研究了米托蒽醌与高剂量胞嘧啶阿拉伯糖苷联合化疗作为挽救疗法在40例急性白血病中的疗效。从1987年5月至1997年10月,疾病复发或对以前的治疗无效的17例急性髓细胞性白血病患者和23例急性淋巴细胞白血病患者在第1至5天接受了5 mg / m〜2 / day的米托蒽醌治疗,胞嘧啶阿拉伯糖苷2 g / m〜2,第1至3天每12小时一次。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号